Using Smartwatches to Monitor Smoking in Real-life Situations
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sherine M El-Toukhy, Ph.D. · PRINCIPAL_INVESTIGATOR · National Institute on Minority Health and Health Disparities (NIMHD)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The primary endpoint is to evaluate changes in biomarker measurements obtained from wearables, which include heart rate, heart rate variability, respiratory rate, blood oxygen levels & hand/arm movement, across three smoking stages.7 days
As the research progresses, the team will work diligently to gather a robust dataset from various sources, including wearable devices, lab sessions, medical-grade information, and detailed questionnaires. This comprehensive approach will enable the identification of specific biomarkers and hand-mouth gestures related to the different stages of tobacco use: pre-smoking, active smoking, and post-smoking. By analyzing these diverse data sources, the team aims to gain valuable insights into the physiological and behavioral patterns associated with each stage. This knowledge will not only enrich our understanding of tobacco use but also pave the way for developing targeted interventions and tailored support systems for individuals seeking to quit smoking. Through collaboration and innovative analysis, this research endeavors to create more effective strategies for smoking cessation, ultimately fostering healthier lifestyles.